[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100584280":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":31,"collaborators":7,"id":33,"slug":34,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":37,"acronym":38,"eligibilityCriteria":39,"healthyVolunteers":40,"sex":41,"minAge":42,"maxAge":7,"enrollmentInfo":43,"targetDuration":46,"studyType":47,"phases":7,"briefSummary":48,"conditions":49,"keywords":52,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"University Hospital, Essen","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Lars Michel, MD","CONTACT","+49 201 72384841","lars.michel@uk-essen.de",[15],{"facility":16,"status":17,"city":18,"state":19,"zip":20,"country":21,"countryCode":22,"cosmosGeoPoint":23,"geoPoint":28,"contacts":29},"University Hospital Essen","RECRUITING","Essen","North Rhine-Westphalia","45147","Germany","DE",{"type":24,"coordinates":25},"Point",[26,27],7.01228,51.45657,{"lat":27,"lon":26},[30],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},{"type":32,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100584280","essen-amyloidosis-registry-100584280",false,"NCT06887283","Essen Amyloidosis Registry","EAR","Inclusion Criteria:\n\n* Suspected or confirmed amyloidosis (any)\n* Written informed consent to participate in the study\n* Age 18 years and above\n\nExclusion Criteria:\n\n* Age \\\u003C 18 years\n* Lack of written informed consent",true,"ALL","18 Years",{"count":44,"type":45},400,"ESTIMATED","12 Months","OBSERVATIONAL","The Essen Amyloidosis Registry (EAR) is a prospective, observational registry designed to collect comprehensive clinical data on patients diagnosed with systemic amyloidosis. The registry aims to improve the understanding of disease progression, diagnostic pathways, and treatment outcomes. The registry is hosted at the University Hospital Essen and follows patients longitudinally. Inclusion is open to all patients with suspected or confirmed amyloidosis who provide informed consent.",[50,51],"Amyloidosis; Systemic","Amyloidosis Cardiac",[53,54,55,56,57],"Amyloidosis","Transthyretin","Light chain amyloidosis","Neuropathy","Cardiomyopathy","2025-08-15",{"date":60,"type":61},"2025-08-21","ACTUAL",{"date":63,"type":61},"2024-05-08",{"date":65,"type":45},"2029-07-01",{"name":5,"class":6},1]